These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1053 related items for PubMed ID: 19447039

  • 21. Synthesis of 1,7-annulated indoles and their applications in the studies of cyclin dependent kinase inhibitors.
    Zhu G, Conner SE, Zhou X, Chan HK, Shih C, Engler TA, Al-Awar RS, Brooks HB, Watkins SA, Spencer CD, Schultz RM, Dempsey JA, Considine EL, Patel BR, Ogg CA, Vasudevan V, Lytle ML.
    Bioorg Med Chem Lett; 2004 Jun 21; 14(12):3057-61. PubMed ID: 15149644
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Synthesis and biological evaluation of 2-indolinone derivatives as potential antitumor agents.
    Zou H, Zhang L, Ouyang J, Giulianotti MA, Yu Y.
    Eur J Med Chem; 2011 Dec 21; 46(12):5970-7. PubMed ID: 22019188
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies.
    Choi WK, El-Gamal MI, Choi HS, Baek D, Oh CH.
    Eur J Med Chem; 2011 Dec 21; 46(12):5754-62. PubMed ID: 22014559
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Synthesis and antitumor activity of 2,5-bis(3'-indolyl)-furans and 3,5-bis(3'-indolyl)-isoxazoles, nortopsentin analogues.
    Diana P, Carbone A, Barraja P, Kelter G, Fiebig HH, Cirrincione G.
    Bioorg Med Chem; 2010 Jun 15; 18(12):4524-9. PubMed ID: 20472437
    [Abstract] [Full Text] [Related]

  • 29. Discovery of novel 4-(2-fluorophenoxy)quinoline derivatives bearing 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety as c-Met kinase inhibitors.
    Li S, Zhao Y, Wang K, Gao Y, Han J, Cui B, Gong P.
    Bioorg Med Chem; 2013 Jun 01; 21(11):2843-55. PubMed ID: 23628470
    [Abstract] [Full Text] [Related]

  • 30. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.
    Lv PC, Li DD, Li QS, Lu X, Xiao ZP, Zhu HL.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5374-7. PubMed ID: 21802290
    [Abstract] [Full Text] [Related]

  • 31. An expeditious synthesis and anticancer activity of novel 4-(3'-indolyl)oxazoles.
    Kumar D, Kumar NM, Sundaree S, Johnson EO, Shah K.
    Eur J Med Chem; 2010 Mar 15; 45(3):1244-9. PubMed ID: 20047778
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β.
    Yang Z, Liu H, Pan B, He F, Pan Z.
    Org Biomol Chem; 2018 Jun 06; 16(22):4127-4140. PubMed ID: 29781013
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
    Zheng M, Xu C, Ma J, Sun Y, Du F, Liu H, Lin L, Li C, Ding J, Chen K, Jiang H.
    Bioorg Med Chem; 2007 Feb 15; 15(4):1815-27. PubMed ID: 17157510
    [Abstract] [Full Text] [Related]

  • 35. Naphthamides as novel and potent vascular endothelial growth factor receptor tyrosine kinase inhibitors: design, synthesis, and evaluation.
    Harmange JC, Weiss MM, Germain J, Polverino AJ, Borg G, Bready J, Chen D, Choquette D, Coxon A, DeMelfi T, DiPietro L, Doerr N, Estrada J, Flynn J, Graceffa RF, Harriman SP, Kaufman S, La DS, Long A, Martin MW, Neervannan S, Patel VF, Potashman M, Regal K, Roveto PM, Schrag ML, Starnes C, Tasker A, Teffera Y, Wang L, White RD, Whittington DA, Zanon R.
    J Med Chem; 2008 Mar 27; 51(6):1649-67. PubMed ID: 18324761
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
    Kumar D, Kumar NM, Akamatsu K, Kusaka E, Harada H, Ito T.
    Bioorg Med Chem Lett; 2010 Jul 01; 20(13):3916-9. PubMed ID: 20627724
    [Abstract] [Full Text] [Related]

  • 37. Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents.
    Jacquemard U, Dias N, Lansiaux A, Bailly C, Logé C, Robert JM, Lozach O, Meijer L, Mérour JY, Routier S.
    Bioorg Med Chem; 2008 May 01; 16(9):4932-53. PubMed ID: 18439832
    [Abstract] [Full Text] [Related]

  • 38. Synthesis and biological evaluation of 1-(4'-Indolyl and 6'-Quinolinyl) indoles as a new class of potent anticancer agents.
    Lai MJ, Chang JY, Lee HY, Kuo CC, Lin MH, Hsieh HP, Chang CY, Wu JS, Wu SY, Shey KS, Liou JP.
    Eur J Med Chem; 2011 Sep 01; 46(9):3623-9. PubMed ID: 21641700
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and antitumor activity of 3-(2-phenyl-1,3-thiazol-4-yl)-1H-indoles and 3-(2-phenyl-1,3-thiazol-4-yl)-1H-7-azaindoles.
    Diana P, Carbone A, Barraja P, Montalbano A, Parrino B, Lopergolo A, Pennati M, Zaffaroni N, Cirrincione G.
    ChemMedChem; 2011 Jul 04; 6(7):1300-9. PubMed ID: 21523912
    [Abstract] [Full Text] [Related]

  • 40. Novel diarylsulfonylurea derivatives as potent antimitotic agents.
    Kim S, Park JH, Koo SY, Kim JI, Kim MH, Kim JE, Jo K, Choi HG, Lee SB, Jung SH.
    Bioorg Med Chem Lett; 2004 Dec 20; 14(24):6075-8. PubMed ID: 15546733
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 53.